Format: Webcast

1-6 of 6 Activities
Title
Availability
Format
Credits
Launch Date
Buttons
Live
Webcast
1
07/17/2024 at 6:30 PM EST

Navigating New Waters for Advanced or Recurrent Endometrial Cancer

Patient prognosis for endometrial cancer (EC) is highly benefited by molecular profiling, and national and international guidelines robustly recommend its integration into practice. Characterization of DNA
In this CE Concepts live webcast, expert faculty will guide learners through integration of appropriate, guideline-directed molecular profiling strategies in the EC risk assessment and treatment decision process. Faculty will also assess the latest efficacy and safety data for the treatment of EC with learners and develop guideline-concordant and patient-specific therapeutic plans for patients with newly diagnosed advanced or recurrent EC that incorporate MDT collaboration strategies.

1
07/17/2024 at 6:30 PM EST

Richard T. Penson, MD, MRCP

Richard T. Penson, MD, MRCP

Moderator

Paula J. Anastasia, MN, RN, AOCN

Paula J. Anastasia, MN, RN, AOCN

Livestream: Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies

This 90-minute livestreamed activity is led by a panel of breast cancer experts who will guide participants through a discussion of criteria to select patients to receive ADCs, adverse event (AE) management, and strategies to foster equitable care of patients with metastatic breast cancer (mBC).

1.5
05/31/2024 at 7:30 PM EST

Deltra James

Deltra James

Patient/Patient Advocate

Lee S. Schwartzberg, MD, FACP

Lee S. Schwartzberg, MD, FACP

Hope S. Rugo, MD, FASCO

Hope S. Rugo, MD, FASCO

Moderator

Srigowri Kota

Srigowri Kota

On-Demand
Webcast
1.5
12/22/2023

The Ever-Changing Options for the Treatment of CLL

The treatment landscape for CLL has changed dramatically in the past 10 years. With three approved BTK inhibitors, and several more on the horizon, choosing which agent to use in the first-line continues to present a challenge to hematologists/oncologists and care teams. As the choice of first-line agent has ramifications for future lines of therapy, hematologists/oncologists need to be able to map out the treatment journey while keeping in mind that therapy resistance or intolerance may arise and that AEs may diminish adherence to therapy.

In this Creative Educational Concepts Enduring Webcast, expert faculty will guide learners through the latest clinical data that informs best practices (including sequencing BTKis), the rationale and support for combination therapies, and the need to factor in the needs and preferences of patients.

1.5
12/22/2023

Matthew S. Davids, MD, MMSc

Matthew S. Davids, MD, MMSc

Kerry A. Rogers, MD

Kerry A. Rogers, MD

Beth  Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO

Beth  Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO

On-Demand
Webcast
1.00
06/27/2023

Talha Munir, PhD

Talha Munir, PhD

Jennifer R. Brown, MD, PhD





Jennifer R. Brown, MD, PhD

Paolo Ghia, MD, PhD



Paolo Ghia, MD, PhD

On-Demand
Webcast
1.00
11/01/2023

Actionable Strategies in Community Oncology to Achieve Equity in Triple-Negative Breast Cancer

This Grand Rounds series focuses on educating, informing, and empowering clinicians involved in the care of patients with triple-negative breast cancer (TNBC) to positively impact the racial/ethnic disparities that negatively impact Black women. Our faculty will explore strategies that promote equitable care and outcomes for all patients; evaluate the role of antibody-drug conjugates (ADCs) in TNBC; and discuss the rapidly evolving clinical practice guidelines, safety and efficacy data of novel therapies, and practical ADC management strategies to anticipate and mitigate adverse events.

Join our expert faculty for this 60-minute program that will help you understand the complexity of TNBC and the far-reaching racial disparities intrinsic to the disease.

 

1.00
11/01/2023

Sonya Reid, MD, MPH

Sonya Reid, MD, MPH

Immunotherapy in Upper GI Cancers: A Multidisciplinary Discussion of the Data and Real-World Barriers Faced in Practice

This is a live webcast addressing emerging therapeutic options for gastric, GEJ, and EAC cancers. This activity will address PD-L1 expression and its impact on treatment selection and sequencing, as well as the role of interprofessional care in managing irAEs. 

1.00
06/05/2023

Kurt A. Schalper, MD, PhD


Kurt A. Schalper, MD, PhD

Kelley A. Rone, DNP, RN, AGNP-c

Kelley A. Rone, DNP, RN, AGNP-c

R. Donald Harvey, PharmD, BCOP, FASCO, FCCP, FHOPA




R. Donald Harvey, PharmD, BCOP, FASCO, FCCP, FHOPA

Yelena Y. Janjigian, MD

Yelena Y. Janjigian, MD